Can a breast cancer drug penetrate brain tumors? new study investigates
NCT ID NCT02933736
First seen Mar 31, 2026 · Last updated May 07, 2026 · Updated 5 times
Summary
This study looks at how well the drug ribociclib gets into brain tumors in people with recurrent high-grade glioma or meningioma. About 48 participants will take the drug before their scheduled tumor removal surgery. The goal is to measure drug levels in the blood, spinal fluid, and tumor tissue to see if it can effectively reach and act on the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barrow Brain and Spine
Phoenix, Arizona, 85013, United States
Conditions
Explore the condition pages connected to this study.